We can't find the internet
Attempting to reconnect
17616.1 PFLS-LS
17616.1 PFLS-LS
Résumé
New therapeutic approach to Alzheimer's disease: assessing active immunization and anti-aggregation small molecules in a novel mouse model of Tau pathology
Textes supplémentaires
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative disease with increasing incidence due to an aging world population and an absence of disease-modifying therapies. Our objective is to develop a novel genetic mouse model to demonstrate efficacy of therapeutics (small molecules and vaccines) to prevent the progression of the Tau pathology in order to evaluate their therapeutic value for testing in AD patients.
Participants
Andreas Muhs
Wirtschaftspartner
AC Immune SA Andreas Muhs Bâtiment B / EPFL Innovation Park 1015 Lausanne VD CH
Bernard Schneider
Kontaktperson
bernard.schneider@epfl.ch
EPFL IC IIF LABOS Bernard Schneider Station 9, Bâtiment AI 2241 1015 Lausanne VD CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-08-31
- Date de fin
- 2018-08-31
- Coûts totaux approuvés
- CHF 385553.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%